Annovis Bio has been told by the NYSE that it might be removed from the stock exchange.

Oct 30, 2026, 5:53 PM ETTroubleRead the original at SEC EDGAR

Bad for ANVS

Annovis Bio’s average market value was about $48.4 million, and its latest reported stockholders’ deficit was about $4.3 million. Its shares can still trade for now, but a rejected or failed plan could lead to removal from the exchange.

ANVS · Annovis Bio, Inc.

AI read · Bad for ANVS

The AI's read

Annovis Bio must send a plan within 45 days and show it can meet the listing rules within 9 months. If the exchange rejects the plan or the company fails to follow it, removal proceedings may begin. Its shares remain listed for now, and the notice does not affect its operations or debt agreements. Those protections soften the blow, but the threat to its exchange listing makes the news unfavorable.

Get alerts for ANVS

Follow Annovis Bio, Inc. (ANVS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ANVS

Free on the App Store and Google Play, or on the web.